Early tumour shrinkage as a prognostic factor and surrogate end-point in colorectal cancer: A systematic review and pooled-analysis
- 1 May 2015
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 51 (7), 800-807
- https://doi.org/10.1016/j.ejca.2015.02.011
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trialThe Lancet Oncology, 2014
- 10% Tumor Diameter Shrinkage on the First Follow-Up Computed Tomography Predicts Clinical Outcome in Patients With Advanced Renal Cell Carcinoma Treated With Angiogenesis Inhibitors: A Follow-Up Validation StudyThe Oncologist, 2014
- Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With SorafenibThe Oncologist, 2014
- Use of Early Tumor Shrinkage to Predict Long-Term Outcome in Metastatic Colorectal Cancer Treated With CetuximabJournal of Clinical Oncology, 2013
- Correlation of progression-free and post-progression survival with overall survival in advanced colorectal cancerAnnals Of Oncology, 2012
- Optimisation of the tumour response threshold in patients treated with everolimus for metastatic renal cell carcinoma: Analysis of response and progression-free survival in the RECORD-1 studyEuropean Journal of Cancer, 2012
- Surrogate End Points for Median Overall Survival in Metastatic Colorectal Cancer: Literature-Based Analysis From 39 Randomized Controlled Trials of First-Line ChemotherapyJournal of Clinical Oncology, 2007
- The power of statistical tests in meta-analysis.Psychological Methods, 2001
- Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysisThe Lancet, 2000
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986